Treatment of patients with diabetic gastroparesis
- PMID: 20733935
- PMCID: PMC2920593
Treatment of patients with diabetic gastroparesis
Abstract
Gastroparesis, or chronic delayed gastric emptying without mechanical obstruction, affects about 40% of patients with type 1 diabetes and up to 30% of patients with type 2 diabetes. Diabetic gastroparesis (DGP) typically causes nausea, vomiting, early satiety, bloating, and postprandial fullness. These symptoms can be extremely troubling and result in poor quality of life. The diagnosis of DGP is made by documenting the presence of chronic upper gastrointestinal (GI) symptoms, ruling out mechanical obstruction, and demonstrating delayed gastric emptying. The usual treatment for DGP includes dietary modifications, prokinetic agents, and antiemetic agents. Although the majority of patients have mild-to-moderate disease that can be managed using these measures, a substantial percentage of patients have severe DGP that is characterized by inadequate oral intake, malnutrition, weight loss, and frequent hospitalizations. Optimal management of these patients presents a difficult challenge for the clinician, although emerging treatment options, such as gastric neurostimulation, are encouraging. Patients with DGP often present with gastric comorbidities, including gastroesophageal reflux disease, intestinal dysmotility, and fungal and bacterial infections of the GI tract. This monograph will present an overview of the pathophysiology of DGP, review diagnostic testing with a discussion of emerging technology, and present the latest research in treatment options for DGP. In addition, management strategies for refractory DGP and gastric comorbidities will be described.
Conflict of interest statement
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kimball, RN, BSN, Samantha Mattiucci, PharmD, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. Jacquelyn Matos: No real or apparent conflicts of interest.
Figures





Similar articles
-
Diabetes and the Stomach.Curr Treat Options Gastroenterol. 2017 Dec;15(4):441-459. doi: 10.1007/s11938-017-0146-y. Curr Treat Options Gastroenterol. 2017. PMID: 28879488 Review.
-
Common Pathophysiological Mechanisms and Treatment of Diabetic Gastroparesis.J Neurogastroenterol Motil. 2024 Apr 30;30(2):143-155. doi: 10.5056/jnm23100. J Neurogastroenterol Motil. 2024. PMID: 38576367 Free PMC article. Review.
-
Diabetic Gastroparesis: Principles and Current Trends in Management.Diabetes Ther. 2018 Jul;9(Suppl 1):1-42. doi: 10.1007/s13300-018-0454-9. Epub 2018 Jun 22. Diabetes Ther. 2018. PMID: 29934758 Free PMC article. Review.
-
Gastric Electrical Stimulation Improves Symptoms of Diabetic Gastroparesis in Patients on Peritoneal Dialysis-2 Case Reports.Perit Dial Int. 2018 Nov-Dec;38(6):458-462. doi: 10.3747/pdi.2018.00063. Perit Dial Int. 2018. PMID: 30413639 Review.
-
Diabetic gastroparesis.Br Med Bull. 2013;105:213-30. doi: 10.1093/bmb/ldt003. Epub 2013 Jan 29. Br Med Bull. 2013. PMID: 23363458 Review.
Cited by
-
An Inductively Powered Implantable System to Study the Gastrointestinal Electrophysiology in Freely Behaving Rodents.Bioengineering (Basel). 2022 Oct 6;9(10):530. doi: 10.3390/bioengineering9100530. Bioengineering (Basel). 2022. PMID: 36290498 Free PMC article.
-
Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.Diabetes Metab J. 2016 Jun;40(3):240-7. doi: 10.4093/dmj.2016.40.3.240. Epub 2016 Apr 21. Diabetes Metab J. 2016. PMID: 27098506 Free PMC article.
-
Physical activity and type 1 diabetes: time for a rewire?J Diabetes Sci Technol. 2015 May;9(3):609-18. doi: 10.1177/1932296814566231. Epub 2015 Jan 6. J Diabetes Sci Technol. 2015. PMID: 25568144 Free PMC article. Review.
-
A Comprehensive Review of Upper Gastrointestinal Symptom Management in Autoimmune Gastritis: Current Insights and Future Directions.Cureus. 2023 Aug 13;15(8):e43418. doi: 10.7759/cureus.43418. eCollection 2023 Aug. Cureus. 2023. PMID: 37706145 Free PMC article. Review.
-
Postprandial plasma glucose response and gastrointestinal symptom severity in patients with diabetic gastroparesis.J Diabetes Sci Technol. 2014 Jul;8(4):881-8. doi: 10.1177/1932296814531098. Epub 2014 May 6. J Diabetes Sci Technol. 2014. PMID: 24876417 Free PMC article.
References
-
- Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24:1264–1269. - PubMed
-
- Lyrenås EB, Olsson EH, Arvidsson UC, et al. Prevalence and determinants of solid and liquid gastric emptying in unstable type I diabetes. Relationship to postprandial blood glucose concentrations. Diabetes Care. 1997;20:413–418. - PubMed
-
- Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia. 1989;32:151–159. - PubMed
-
- Lyrenas E, Olsson E, Arvidsson U, et al. Prevalence and determinants of solid and liquid gastric emptying in unstable type 1 diabetes: relationship to postprandial blood glucose concentrations. Diabetes Care. 1997;20:413–418. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources